Cynosure Company Profile (NASDAQ:CYNO)

Analyst Ratings

Consensus Ratings for Cynosure (NASDAQ:CYNO) (?)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $58.60 (6.62% upside)

Analysts' Ratings History for Cynosure (NASDAQ:CYNO)
Show:
DateFirmActionRatingPrice TargetActions
7/28/2016Brean CapitalReiterated RatingBuy$54.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/27/2016Northland SecuritiesSet Price TargetBuy$55.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/27/2016Stifel NicolausReiterated RatingBuy$57.00 -> $62.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/27/2016Maxim GroupBoost Price TargetBuy$60.00 -> $66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2015Northcoast ResearchInitiated CoverageBuy$41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2015Tigress FinancialInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/31/2014 forward)

Earnings

Earnings History for Cynosure (NASDAQ:CYNO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
10/25/2016        
7/26/2016Q216$0.29$0.36$101.31 million$110.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2016Q116$0.14$0.19$85.78 million$94.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/9/2016Q415$0.38$0.42$95.01 million$102.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2015Q315$0.18$0.21$76.68 million$78.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2015Q215$0.29$0.30$82.71 million$83.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q1$0.09$0.15$70.87 million$74.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2015Q414$0.39$0.36$83.01 million$86.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2014Q314$0.24$0.25$69.94 million$71.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2014Q214$0.29$0.32$71.15 million$72.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2014Q1$0.23$0.19$64.70 million$62.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/12/2014Q413$0.19$0.39$67.80 million$74.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2013Q313$0.19$0.23$61.60 million$60.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2013Q2 2013$0.20$0.29$46.96 million$50.09 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2013Q1 2013$0.13$0.12$38.51 million$10.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/12/2013Q4 2012$0.23$0.27$40.98 million$47.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2012$0.12$0.25ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2012$0.12$0.20ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2012($0.02)$0.06ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/14/2012$0.05$0.08ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2011$0.04($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2011($0.05)($0.15)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/15/2011($0.03)($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cynosure (NASDAQ:CYNO)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.13$0.26$0.18
Q2 20165$0.27$0.37$0.31
Q3 20165$0.21$0.35$0.30
Q4 20163$0.49$0.71$0.57
Q1 20173$0.22$0.33$0.29
Q2 20173$0.49$0.54$0.51
Q3 20173$0.31$0.44$0.39
Q4 20173$0.65$0.84$0.72
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Cynosure (NASDAQ:CYNO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cynosure (NASDAQ:CYNO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/13/2016Douglas J DelaneyVPSell12,299$46.60$573,133.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2016Michael R DavinCEOSell26,271$46.59$1,223,965.89View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2016Timothy W BakerCFOSell12,451$46.60$580,216.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/18/2016Douglas J DelaneyVPSell15,890$45.01$715,208.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/18/2016Michael R DavinCEOSell74,729$45.31$3,385,970.99View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/18/2016Timothy W BakerCFOSell14,008$45.02$630,640.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2016Douglas J DelaneyVPSell24,488$45.02$1,102,449.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2016Michael R DavinCEOSell61,377$45.01$2,762,578.77View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2016Timothy W BakerCFOSell39,857$45.02$1,794,362.14View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/13/2016Michael R DavinCEOSell72$45.00$3,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2016Douglas J DelaneyVPSell4,408$45.08$198,712.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2016Michael R DavinCEOSell4,869$45.11$219,640.59View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2016Timothy W BakerCFOSell4,413$45.08$198,938.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2016Douglas J DelaneyVPSell66,626$45.47$3,029,484.22View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2016Michael R DavinCEOSell66,259$45.61$3,022,072.99View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2016Timothy W BakerCFOSell53,297$45.60$2,430,343.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/31/2015Michael R. DavinCEOSell200$45.00$9,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/31/2015Timothy W. BakerCFOSell100$45.00$4,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2015Ettore V BiagioniDirectorSell24,000$36.25$870,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2015Douglas J DelaneyVPSell89,000$38.01$3,382,890.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2015Michael R DavinCEOSell151,000$38.07$5,748,570.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/23/2015Michael R DavinCEOSell6,991$33.04$230,982.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/10/2015Michael R DavinCEOSell44,677$33.01$1,474,787.77View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/9/2015Douglas J DelaneyVPSell28,335$33.01$935,338.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/9/2015Michael R DavinCEOSell70,000$32.00$2,240,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2015Douglas J DelaneyVPSell45,000$32.00$1,440,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2015Ettore V BiagioniDirectorSell12,000$30.09$361,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2014Ettore V BiagioniDirectorSell2,500$28.00$70,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/24/2014Ettore V BiagioniDirectorSell5,000$27.28$136,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/5/2013Marina HatsopoulosDirectorBuy3,000$22.60$67,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2012Douglas J DelaneyVPSell16,904$27.65$467,395.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2012Michael R DavinCEOSell16,770$27.65$463,690.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2012Timothy W BakerCFOSell16,854$27.65$466,013.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Cynosure (NASDAQ:CYNO)
DateHeadline
07/29/16 08:54 PMBrokers Issue Average Price Target Of 47.59 On Cynosure, Inc. (NASDAQ:CYNO) - FTSE News
07/28/16 04:32 PMCynosure Inc. (CYNO) Hits New 52-week High During July 26 Session - Equities.com
07/28/16 04:32 PMCynosure Still Looks Attractive After A Bull Run - Seeking Alpha
07/28/16 09:41 AMCynosure Reports Net Income of $6.3 Million on Record Sales of $110.3 Million for the Second Quarter of 2016
07/28/16 09:41 AMCynosure Inc. (CYNO) Hits New 52-week High During July 26 Session
07/27/16 10:00 AMCynosure Inc (NASDAQ:CYNO) nearing 52-week high, short interest stable - Street Report
07/27/16 06:24 AM7:24 am Cynosure target raised to $66 rom $60 at Maxim Group -
07/26/16 09:37 PMCynosure Inc.: Cynosure Reports Net Income of $6.3 Million on Record Sales of $110.3 Million for the Second Quarter ... - The Wall Street Transcript
07/26/16 03:53 PMEdited Transcript of CYNO earnings conference call or presentation 26-Jul-16 1:00pm GMT -
07/26/16 11:48 AMCynosure Receives Approval to Market SculpSure® in South Korea
07/26/16 11:48 AMCynosure beats Street 2Q forecasts
07/26/16 11:48 AMCynosure Inc.: Cynosure Reports Net Income of $6.3 Million on Record Sales of $110.3 Million for the Second Quarter of 2016
07/26/16 09:08 AMCynosure, Inc. (Nasdaq: CYNO) to Ring The Nasdaq Stock Market Closing Bell - [at noodls] - ADVISORY, July 26, 2016 (GLOBE NEWSWIRE) -- What: Cynosure, Inc. (Nasdaq:CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic and medical treatment systems, will visit ...
07/25/16 09:59 AMMed-Instrument Stocks to Post Earnings: EW, CYNO, GMED -
07/23/16 03:27 PMCynosure : To Host Second-Quarter 2016 Financial Results Conference Call On July 26
07/23/16 07:41 AMCYNOSURE INC : Change in Directors or Principal Officers (form 8-K)
07/22/16 03:32 PMCYNOSURE INC Files SEC form 8-K, Change in Directors or Principal Officers -
07/22/16 03:28 PMFirms and Funds Increasing Their Stake in Cynosure, Inc. (NASDAQ:CYNO) - Engelwood Daily
07/22/16 08:49 AMMedical aesthetics market to grow at a CAGR of 10.8% by 2020 scrutinized in new research
07/22/16 08:49 AMSkincare Devices Industry Global Analysis by Region, vendors, Market challenge and Technology Forecasts 2022
07/21/16 09:02 PMInstitutions Increasing Their Positions in Cynosure, Inc. (NASDAQ:CYNO) - Engelwood Daily
07/21/16 03:41 PMAnti-Ageing Market to Grow at a CAGR of 8.0% Through 2019
07/21/16 12:55 PMETF’s with exposure to Cynosure, Inc. : July 21, 2016 -
07/21/16 04:16 AMEarnings Focus and Crowd Sourced Sentiment Review for Cynosure, Inc. (NASDAQ:CYNO) - TGP
07/20/16 04:42 PMAesthetic Equipment Market - Global Industry Analysis, Growth, Trends, Forecast 2019
07/20/16 04:42 PMMajor Second Quarter Purchases for Cohen include Tesaro, Pernix
07/20/16 08:52 AMBroker Outlook For Cynosure, Inc. (NASDAQ:CYNO) - Fiscal Standard
07/19/16 08:51 PMInsight Capital Research & Management INC Increased Cynosure ... - Consumer Eagle
07/19/16 03:37 PMCynosure, Inc. (NASDAQ:CYNO): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/19/16 09:39 AMCynosure, Inc. (NASDAQ:CYNO) Broker Price Targets For The Coming Week - Fiscal Standard
07/19/16 09:39 AMStock in Positive Territory for the Quarter: Cynosure, Inc. (NASDAQ:CYNO) - Engelwood Daily
07/19/16 09:39 AMCan Cynosure, Inc. (NASDAQ:CYNO) Surprise Analysts this Quarter? - Investor Newswire
07/19/16 09:39 AMShare Performance Summary for: Cynosure, Inc. (NASDAQ:CYNO) - Press Telegraph
07/19/16 09:39 AMCynosure Inc Realized Volatility Hits Elevated Level - CML News
07/17/16 08:06 AMAnti-ageing Market: Anti-wrinkle Products Witnessing High Demand
07/16/16 03:26 PMShares Moving Down on the Week: Cynosure, Inc. (NASDAQ:CYNO) - Engelwood Daily
07/16/16 03:26 PMWill Cynosure, Inc. (NASDAQ:CYNO) Surprise Analysts? - Investor Newswire
07/15/16 07:34 PMInstitutions are Increasing Positions in Cynosure, Inc. (NASDAQ:CYNO) - Engelwood Daily
07/15/16 07:34 PMCynosure Inc.: Cynosure To Host Second-Quarter 2016 Financial Results Conference Call On July 26 - The Wall Street Transcript
07/14/16 03:48 PMCynosure Inc.: Cynosure To Host Second-Quarter 2016 Financial Results Conference Call On July 26
07/14/16 07:30 AMCynosure To Host Second-Quarter 2016 Financial Results Conference Call On July 26 - [PR Newswire] - WESTFORD, Mass., July 14, 2016 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO), which designs, manufactures and markets medical devices for aesthetic procedures and precision surgical applications worldwide, ...
07/13/16 03:38 PMAnalyst Target and Average Rating Watch: Cynosure, Inc. (NASDAQ:CYNO) - Press Telegraph
07/13/16 03:38 PMAnalyst Target and Average Rating Watch: Cynosure, Inc. (NASDAQ:CYNO) - Press Telegraph
07/13/16 09:36 AMShares Trading unchanged at $52.28 Cynosure Receives Health Canada…
07/13/16 07:58 AMCynosure Receives Health Canada Authorization to Market SculpSure® - [at noodls] - WESTFORD, Mass., July 13, 2016 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO) today announced that it has received a medical device license issued by Health Canada to market SculpSure for non-invasive lipolysis ...
07/12/16 03:41 PMCynosure, Inc. (NASDAQ:CYNO) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/12/16 03:41 PMInsight Capital Research & Management INC Increased Cynosure INC (NASDAQ:CYNO) by $3.99 Million as Shares ... - Press Telegraph
07/11/16 08:23 AMStock Performance Rundown on: Cynosure, Inc. (NASDAQ:CYNO) - Press Telegraph
07/10/16 07:33 PMNew Trial Agreement with Cynosure Private Equity - 11 July 2016 - [at noodls] - edc39330-b88b-4161-b2c6-780dc9d1ad88.pdf 11 July 2016 Zyber Announces New Trial Agreement The Board of Directors of Zyber Holdings Limited (ASX: ZYB) ('Zyber' or 'the Company'), is pleased to announce ...
07/09/16 04:01 AMCynosure, Inc. versus NovoCure Limited Head to Head Compare - CML News

Social

About Cynosure

Cynosure logoCynosure Inc. (Cynosure) develops and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve gynecologic health. The Company operates through aesthetic treatment products and services segment. It markets radiofrequency (RF) energy sourced medical devices for precision surgical applications, such as facial plastic and general surgery; gynecology; ear, nose and throat procedures; ophthalmology; oral and maxillofacial surgery; podiatry, and proctology. The Company's product portfolio utilizes a range of energy sources, including Alexandrite, diode, neodymium-doped yttrium aluminum garnet (Nd: YAG), pulse dye, Q-switched lasers, intense pulsed light and RF technology.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: CYNO
  • CUSIP: 23257720
Key Metrics:
  • Previous Close: $54.96
  • 50 Day Moving Average: $50.27
  • 200 Day Moving Average: $44.75
  • P/E Ratio: 64.89
  • P/E Growth: 1.83
  • Market Cap: $1.28B
  • Beta: 1.6
  • Current Year EPS Consensus Estimate: $1.33 EPS
  • Next Year EPS Consensus Estimate: $1.93 EPS
Additional Links:
Cynosure (NASDAQ:CYNO) Chart for Sunday, July, 31, 2016